Process for preparing recombinant natookinase

A nattokinase and coding technology, which is applied to the coding nucleotide sequence of recombinant nattokinase and its preparation field, can solve the problems of low yield, high cost, low yield and the like

Inactive Publication Date: 2005-02-09
常荣山
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The yield of natural NK in fermented liquid of wild bacteria is low (<10%), the extraction method is cumbersome, the yield is low, and the cost is high, and wild bacteria are prone to mutation and difficult to control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparing recombinant natookinase
  • Process for preparing recombinant natookinase
  • Process for preparing recombinant natookinase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] The construction and expression of embodiment one nattokinase gene expression vector:

[0067] 1. Extract total bacterial DNA from Bacillus subtilis notto: Inoculate Bacillus subtilis notto in LB medium, culture at 37°C and shake at 250rpm / min for 16 hours. Centrifuge at 500rpm / min for 10 minutes, collect the bacterial mass and resuspend in TE buffer, add SDS and proteinase K, and incubate at 37°C for 1 hour. Add NaCl, mix with CTAB, and incubate at 65°C for 10 minutes. Add an equal volume of chloroform / isoamyl alcohol for extraction, centrifuge and separate, and then extract the upper layer with an equal volume of phenol / chloroform / isoamyl alcohol. After centrifugation, add 0.6 times the volume of isoamyl alcohol to the upper layer, and centrifuge to precipitate. % ethanol was washed twice, drained and dissolved in TE buffer solution. Ultraviolet spectroscopic detection proved that A260 / A280>2.0.

[0068] 2. Amplify the nattokinase gene with the PCR method:

[0069]...

Embodiment 2

[0108] Embodiment two: large-scale preparation of genetically engineered nattokinase:

[0109] 1. Fermentation of engineering bacteria BVNK:

[0110] (1) Shake flask fermentation:

[0111] The monoclonal engineering bacteria BVNK was inoculated in LBG-ampicillin (100ug / ml) culture solution and cultured overnight at 30°C. The next day, it was diluted 1:50, shaken fully to OD600 0.4-0.6, and incubated at 42°C for 6 hours. The bacterial solution was centrifuged at 5000 rpm / min for 10 minutes at 4°C in a centrifuge tube used for weighing. The supernatant was discarded, and the pellet was washed once with PBS (pH 7.4), centrifuged and weighed.

[0112] (2) Fermentation tank (5L) fermentation:

[0113] BVNK monoclonal inoculation in 100ml LBG-ampicillin (100ug / ml) culture medium, cultivated overnight at 30°C, transferred to a fermenter at a ratio of 1:50 the next day, set the temperature at 30°C, pH6-8, dissolved oxygen 50%- 80%, the stirring speed is 600 r / min (stirring speed ...

Embodiment 3

[0130] Embodiment three uses the present invention to prepare recombinant nattokinase and carries out animal experiments:

[0131] 1. Acute toxicity test of recombinant nattokinase on mice.

[0132] 40 healthy mice, half male and half male, were randomly divided into 4 groups according to body weight. There were 10 mice in each group, dose interval K=0.48, different doses of drugs were injected into the tail vein of the mice respectively, the volume of administration was 0.5ml / 20kg body weight, and the reaction and death of the mice were observed after administration. According to BLISS statistical method to calculate LD50=8.54mg / kg

[0133] 2. Pharmacodynamic study of recombinant nattokinase

[0134] (1) The effect of intravenous injection of recombinant nattokinase on carotid thrombus formation in rats. 50 male rats were randomly divided into 5 groups, 10 rats in each group, respectively: Natrate recombinant soybean kinase large dosage group 6.0mg / kg, medium dosage group ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The nattokinase is a safe high-effective enzyme preparation with fibrinolytic activity. Said invention uses the gene enginering method to implement expression of nottokinase with fabrinolytic activity. As compared with natural nattokinase, said invented recombinant product possesses excellent biological activity. The tests shw that the nattokinase possesses the excellent thrombolytic action and can accelerate production of endogeneous t-PA, so that it can directly and indirectly accelerate thrombolytic action, and at the same time, it is high in safety and easy for oral therapy.

Description

technical field [0001] The invention relates to a coding nucleotide sequence of recombinant nattokinase and a preparation method thereof. Background technique [0002] Nattokinase is a high-efficiency thrombolytic enzyme with the highest safety that can achieve the purpose of oral fibrinolysis, screened from hundreds of foods in the world. At present, the thrombolytic agents widely used clinically are mainly streptokinase, urokinase, prourokinase, recombinant human plasminogen activator (t-PA) and the like. Some of the above drugs are prone to anti-reperfusion in clinical use, and embolism, hemorrhage, allergic reactions and other reactions occur again. NK is a thrombolytic drug that can be taken orally and has high safety. A series of in vitro experiments, mouse and dog models, and healthy human tests have shown that NK has high fibrinolytic properties with high oral and intravenous infusion safety and high performance. It can be used not only for the treatment of variou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/45A61P7/02C12N9/12C12N15/54C12N15/70
Inventor 常荣山
Owner 常荣山
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap